Guiyang
Total1
Listen: China Money Podcast: A $700 Million Series A, Biden Shuts Out Huawei, Inner Mongolia Halts Crypto and Over 70 PE/VC Deals This Week In China
In this episode of China Money Podcast, listen to all the news headlines in the China venture investment and tech sector for the week ending March 12.
We are nearing the ides of March 2021, and in the past 5 business days we counted over 70 deals closing with private equity and VC firms in China with a combined raise of more than US$2.3 billion in everything from seed to pre-IPO rounds. And one firm even raised a whopping 700 million in its Series A, while we saw other news concerning Huawei, AstraZeneca, and Xpeng Motors dominate the investment headlines. Startups in China this week raised funding from over 250 corporate venture capital, private equity and regular venture capital firms like Matrix Partners China, Hillhouse Capital, Warburg Pincus, Shenzhen Capital Group, Lilly Asia Ventures, Hina Group, Fengrun Inve
Carlyle-backed Chinese biotech firm Abbisko Therapeutics plans HK IPO
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.
Oxford Covid-19 Vaccine Startup in Conflict with University Ahead of Planned IPO
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
General Atlantic, IDG lead $100m fourth round for Chinese biotech firm Biotheus
Source: National Cancer Institute/Unsplash
March 4, 2021
Biotheus, a Chinese biotech firm focusing on the treatment of malignant tumours and autoimmune diseases, has secured over $100 million in its fourth funding round co-led by growth equity investor General Atlantic and Beijing-based investment firm IDG Capital.
New investors in the round include Chinese private equity (PE) firm Kunlun Capital, CITIC’s asset management firm CPE, and Shenzhen-based PE Cowin Capital, Biotheus said in a statement on Wednesday.
Returning investors such as healthcare-focused investment companies HighLight Capital and Shiyu Capital, Chinese fund manager New Alliance Capital, and Huajin Investment participated in the deal.
Canadian, Asian alternatives fundraises among $390m of new LACERA commitments
altassets.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from altassets.net Daily Mail and Mail on Sunday newspapers.